Naloxone Hci Injection, Solution
Product Images NDC 51662-1242

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Naloxone Hci (NDC 51662-1242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image)

Chemical structure of naloxone hydrochloride (NALOXONE HCI) showing the molecular arrangement of atoms including hydroxyl groups, aromatic ring, and hydrochloride component.*

FDA Label Image

How Supplied (How Supplied)

A data table listing three NDC numbers for Naloxone HCl solutions, showing container types (single-dose ampul, single-dose fliptop vial, multiple-dose fliptop vial) and their concentration values (0.4 mg/mL and 0.4 mg/mL in different vial sizes, with one at 4 mg/10 mL).*

FDA Label Image

Logo (Logo)

FDA Label Image

1 mL Vial Label (1000450 0409 1215 01 Naloxone Vial)

Label for NALOXONE HCI injection, USP 0.4 mg/mL, 1 mL single-dose vial, for intravenous, intramuscular, or subcutaneous use. The label includes the NDC 0409-1215-01 and is produced by Hospira, Inc., Lake Forest, IL. It instructs to protect from light and notes prescription use only.*

FDA Label Image

Serialized Label (51662 1242 1 Naloxone Injection 1)

NALOXONE HCI 0.4 mg/mL injection solution vial with orange cap. The label includes usage for intramuscular, intravenous, and subcutaneous routes. Distributed by HF Acquisition Co. LLC, Mukilteo, WA. The vial is a 1 mL single-dose injectable solution, marked for prescription use only.*

FDA Label Image

Pouch Label (51662 1242 2)

Label for NALOXONE HCl Injection USP 0.4 mg/mL in a 1 mL vial. The label shows NDC 51662-1242-2, batch lot HF1234TESTING, and expiration date 2023-09-19. It includes storage and usage instructions for intravenous, intramuscular, or subcutaneous use, and notes it is distributed by HF Acquisition Co. LLC, Mukilteo, WA.*

FDA Label Image

Serialized Case Label (5166212423 Label)

Label for NALOXONE HCI injection, USP 0.4 mg/mL, 1 mL vial, box of 50, with NDC 51662-1242-3. The label includes lot number, expiration date 2021-06-01, storage instructions at 20 to 25°C, and states the product is for intravenous, intramuscular, or subcutaneous use. Distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. The label also includes a QR code and RX only designation.*

FDA Label Image

Rfid Label (51662 1242 3 Rfid)

NALOXONE HCI injection solution label showing a product identifier barcode with numeric codes, a QR code, and text including "SEE MANUFACTURE'S INSERT" and distributor information for HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label is white with black text and includes serial and lot numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.